Companies / Nautilus Biotechnology, Inc. / Activity
Activity — Nautilus Biotechnology, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C. 10% owner | Sell | Common Stock | $10.85M | -4.6M -28.32% | 11,682,032 9.18% of shares | high |
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C. 10% owner | Sell | Common Stock | $902.5K | -384K -28.32% | 971,885 0.76% of shares | medium |
| Mar 4, 2026 | Sujal Patel CEO | Buy | Common Stock | $65.2K | +25K +0.24% | 10,366,721 8.15% of shares | medium |
| Jun 18, 2026 | McIlwain Matthew S Director | Grant | Stock Option (Right to Buy) | — | +45K | 45,000 0.04% of shares | low |
| Jun 18, 2026 | Nazem Farzad Director | Grant | Stock Option (Right to Buy) | — | +45K | 45,000 0.04% of shares | low |
| Mar 2, 2026 | Suzuki Kentaro Executive | Grant | Stock Option (Right to Buy) | — | +160K | 160,000 0.13% of shares | low |
| Mar 2, 2026 | Murphy Matthew B. Executive | Grant | Stock Option (Right to Buy) | — | +160K | 160,000 0.13% of shares | low |
| Mar 2, 2026 | Parag Mallick Executive | Grant | Stock Option (Right to Buy) | — | +280K | 280,000 0.22% of shares | low |
| Mar 2, 2026 | Mowry Anna Executive | Grant | Stock Option (Right to Buy) | — | +160K | 160,000 0.13% of shares | low |
| Mar 2, 2026 | Sankar Subramanian Executive | Grant | Stock Option (Right to Buy) | — | +160K | 160,000 0.13% of shares | low |
| Mar 2, 2026 | Weld Gwen E Executive | Grant | Stock Option (Right to Buy) | — | +160K | 160,000 0.13% of shares | low |
| Mar 2, 2026 | Sujal Patel CEO | Grant | Stock Option (Right to Buy) | — | +650K | 650,000 0.51% of shares | low |